These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 6135735)

  • 21. [Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects].
    Dölle W; Daiss W
    Verh Dtsch Ges Inn Med; 1988; 94():184-91. PubMed ID: 2905099
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine].
    Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B
    Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfasalazine: I. An historical perspective.
    Bachrach WH
    Am J Gastroenterol; 1988 May; 83(5):487-96. PubMed ID: 2896458
    [No Abstract]   [Full Text] [Related]  

  • 24. [Azulfidine/Salazopyrin therapy during pregnancy].
    Fahrländer H
    Z Gastroenterol Verh; 1981 Jun; 19():24-6. PubMed ID: 6168128
    [No Abstract]   [Full Text] [Related]  

  • 25. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).
    Franklin JL; Rosenberg HH
    Gastroenterology; 1973 Apr; 64(4):517-25. PubMed ID: 4144775
    [No Abstract]   [Full Text] [Related]  

  • 26. Imparied lymphocyte responsiveness in inflammatory bowel disease.
    Sachar DB; Taub RN; Brown SM; Present DH; Korelitz BI; Janowitz HD
    Gastroenterology; 1973 Feb; 64(2):203-9. PubMed ID: 4405597
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug management of inflammatory bowel disease.
    McCarthy CF
    Ir Med J; 1983 May; 76(5):260-2. PubMed ID: 6135675
    [No Abstract]   [Full Text] [Related]  

  • 28. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical treatment of ulcerative colitis and Crohn's disease.
    Rhodes JM
    J Clin Hosp Pharm; 1983 Sep; 8(3):219-32. PubMed ID: 6138368
    [No Abstract]   [Full Text] [Related]  

  • 30. 1986 Stuart distinguished lecture. The "natural history" of inflammatory bowel disease and therapeutic decisions.
    Janowitz HD
    Am J Gastroenterol; 1987 Jun; 82(6):498-503. PubMed ID: 2883884
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunology of inflammatory bowel disease.
    MacKechnie HL
    Henry Ford Hosp Med J; 1982; 30(1):25-32. PubMed ID: 6123493
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug information. Pentasa--new Danish drug].
    Dahlerup J
    Sygeplejersken; 1988 Jul; 88(28):16. PubMed ID: 2902698
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic experience with ulcerative colitis and Crohn disease].
    Nagy G; Prónay G; Ujszászy L
    Orv Hetil; 1985 Jan; 126(1):17-20, 23-4. PubMed ID: 2857480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].
    Delboy H
    Therapie; 1992; 47(2):157-9. PubMed ID: 1357770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease.
    Banatwala N
    J Pak Med Assoc; 1985 Mar; 35(3):64-8. PubMed ID: 2860256
    [No Abstract]   [Full Text] [Related]  

  • 37. [Progress in inflammatory diseases of the colon (author's transl)].
    Egger G
    Ther Umsch; 1974 Nov; 31(11):804-9. PubMed ID: 4154520
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possible mechanism of action of Azulfidine/Salazopyrin].
    Campbell DE
    Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
    [No Abstract]   [Full Text] [Related]  

  • 39. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
    Ewe K
    Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.